Professional Documents
Culture Documents
Nama : ROCHSISMANDOKO
Tempat / Tgl lahir : Lahat,27 September 1957
Alamat Rumah : De Park,Cluster Cajuputi
Blok AC 2/3, BSD City
Riwayat pendidikan :
1. Dokter Umum,FK UNSRI, 1984
2. Spesialis Penyakit Dalam, FK UNSRI 1994
3. Konsultan Endokrin Metabolik dan Diabetes,FKUI,2009
Riwayat pekerjaan :
1. Puskesmas Ds Toari,Kab.Kolaka,Prov.SulawesiTenggara,19851988
2. RSUP Palembang, 1988 1994
3. RSUD Dr.M.Azhari,Kab.Pemalang,Prov.Jawa Tengah,1994 - 1999
4. RSUP Persahabatan,1999-sekarang
5. Dosen Pendidik Klinis FKUI
6. Garuda Indonesia
7. Bethsaida Hospital, Paramount Serpong,Tangerang
Organisasi : Ketua Perkumpulan Edukator doabetes Indonesia
Ketua Persatuan Diabetes Indonesia wilayah banten
Strike The Spike!
Strategies for Combatting
After-Meal Highs
Rochsismandoko
RSUP Persahabatan, Jakarta
The question is not whether to
target postprandial,
preprandial or fasting
glycemia, but when, how, and
to what goals.
After-Meal Peaks Defined
HbA1c
FPG
2 hr PPG
Normalization of Glycemia
To achieve a normal or near normal
HbA1c, both FPG and PPG levels
must be normal or near normal.
8 AM 11 AM 2 PM 5 PM
60% 55%
70%
60%
FPG
%
40% PPG
70%
45% 50%
20% 40%
30%
0%
< 10.2 10.2 to 9.3 9.2 to 8.5 8.4 to 7.3 < 7.3
A1C Range (%)
60 *
*
*
40
20
0
4.7-6.2 6.2-6.8 6.8-7.3 7.3-7.8 7.8-8.9 8.9-15.0
HbA1c sixtiles(%)
2.5
2.0
Hazard ratio
1.5
1.0
11.1
0.5 7.811.0
0.0 <7.8
<6.1 6.16.9 7.0
Fasting plasma glucose (mmol/l)
Adjusted for age, center, sex
DECODE Study Group. Lancet 1999;354:617621
Hoorn Study 2-h glucose better predictor of mortality
than HbA1c
Honolulu Heart 1-h glucose predicts coronary heart disease
Program
Chicago Heart Study 2-h postchallenge glucose predicts all-
cause mortality
DECODE High 2-h postload BG is associated with
increased risk of death, independent of
fasting glucose
Coutinho et al. 2-h glucose associated with CHD
Whitehall Study, Paris 2-h postchallenge glucose predicts all-
Prospective Study, cause and CHD mortality
Helsinki Policemen
Study
Diabetes Intervention Postmeal but not fasting glucose is
Study associated with CHD
Long-Term Problems
52 Type 1s, similar BP between groups
70%
60%
50%
40% ppg >275
30% ppg 210-275
20%
10% ppg <210
0%
ppi < 108 ppi 108-210 ppi > 210
Source: Osaka Univ. School of Medicine. Diabetes Care (28): 11, 2806.
So How Can We Assess Post-Prandial
Glucose Control Clinically ??
Frequent fingersticks
HbA1C
Fructosamine
Continuous Glucose
Monitoring Systems
Historical
Real-time
1,5 Anhydroglucitol
Approaches/Agents That Address
Postprandial Hyperglycemia
Meglitinides
Alpha-Glucosidase Inhibitors
Prandial Insulin
GLP-1 analogues
DPP-IV inhibitors
Pramlintide
Glycemic Index/Load
Acute hyperglycemia potentially contributing
to the development of diabetic complications.
G. Paolisso et al.
16
EVIDENCE STATEMENTS
Postmeal hyperglycaemia are independently
associated with the following in people with DM
macrovascular disease
retinopathy
cancer
impaired cognitive function in elderly people
with type 2 diabetes
increased carotid intima-media thickness
decreased myocardial blood volume and
myocardial blood flow
oxidative stress, inflammation and endothelial
dysfunction
17
18
19
20
21
22
23
24
1. Does tighter glycemic control
matter?
2. How does postprandial glucose
relate to overall glycemic levels?
3. Is postprandial glucose control an
independent contributor to diabetes
outcomes?
4. Is postprandial glucose control safe
for most patients?
5. Is postprandial glucose control
practical in primary care settings?
25
Does tighter glycemic control matter?
26
How does postprandial glucose
relate to overall glycemic levels?
Bonora et al showed that A1C levels are more closely related to
preprandial than to postprandial glucose levels, even though
the majority of patients studied had extremely elevated glucose
excursions with meals and extended periods of postprandial
hyperglycemia
27
The first step in the deterioration of glucose
homeostasis is the loss of postprandial glycemic
control, which is followed by a progression to
morning hyperglycemia and eventually to sustained
nocturnal hyperglycemia
33
Tool Postprandial
DescriptionHyperglycemia
Drawbacks Assessment
Tools
HbA1C Mean of last Can mask extremes; cannot change quickly
60-90 days Interferences (hemoglobinopathies)
Individual variability in glycosylation rates
Fructosamine Mean of last Can mask extremes
3-4 weeks Individual variability in glycosylation rates
Oral Glucose Tolerance Multiple data points Good measure of postprandial glucose but time-
Test (75 gr load) on one day consuming for patients and providers
Only measures one day in time so could be skewed
by illness or stress
Continuous Glucose 24/7 continuous Excellent tool but cost and reimbursement is issue
Monitors blood glucose for T2D and some T1D
measurements Time-consuming training and report review
Some patients will not wear sensor 24/7
Frequent Fingerstick Single data points Can miss peaks due to timing
Blood Glucoses Patient adherence to frequent PPG testing
Cost and insurance limits on BG strip quantity
Unreadable/inaccurate glucose logbooks
1,5-Anhydroglucitol 1-2 week measure Not accurate in advanced kidney or liver disease
(1,5-AG; GLYCOMARK) of average peak Individual variability in renal thresholds especially
blood glucose during pregnancy
After-Meal Spike Reduction
Meal choices
Lifestyle Approaches
Medicinal Approaches
Glycemic Index
All carbs (except fiber) convert to blood glucose
eventually
G.I. Reflects the magnitude of blood glucose
rise for the first 2 hours following ingestion
G.I. Number is % or rise relative to pure
glucose (100% of glucose is in bloodstream
within 2 hours)
Glycemic Index
Use of Glycemic Index Fastest Glucose
Lower GI foods digest & Dextrose
+ peripheral
hepatic renal glucose
glucose glucose uptake
production excretion
SGLT2 Inhibitors Adapted from: Inzucchi SE, Sherwin RS in: Cecil Medicine 2011
Summary of Glucose Lowering Intervention
Intervention DM type 2 Hyperglycemia Expected decrease
Pathogenesis target in A1C (%)
Lifestyle Insulin resistance Basal Prandial 12
Modification
Insulin Insulin resistance Basal Prandial 1,5 3,5
B cell dysfunction
Metformin Insulin resistance Basal Prandial? 12